DanCann Pharma A/S: Market update for penetration of the Danish market, cf. the Danish Pilot Programme with medical cannabis
COPENHAGEN, Denmark, 26 April 2021 - DanCann Pharma A/S (SS: DANCAN) (“DanCann Pharma” or the “Company”) hereby provides an update on its market penetration of the Danish market, cf. the Danish Pilot Programme with medical cannabis.DanCann Pharma has had an intensive spring so far with a focus on, among other things, the completion of the new high-tech production facilities, building a powerful and professional organization to prepare all the Company's processes, as well as negotiations on distribution agreements and dialogues around various application processes with authorities (the